The euphoria that swept through D-Wave Quantum in mid-April has given way to a sobering reality check. After Nvidia’s announcement of new AI models designed to turbocharge quantum processors sent the stock on a wild ride—from around $13 to above $22 in a matter of days—the shares have retreated sharply. On Friday, the stock closed at $18.49, down roughly 3.5% from the previous session, with trading volume slumping to just 18 million shares against a daily average of nearly 45 million. Market participants see this not as a panic-driven selloff but as the natural dissipation of speculative momentum.
The company now faces a critical juncture. On May 12, 2026, before the U.S. market opens, D-Wave will report its first-quarter results. The earnings release will serve as a litmus test for whether the staggering order intake reported in January—worth over $30 million in a single month, eclipsing the entire prior year—has translated into tangible revenue. CEO Alan Baratz and CFO John Markovich must convince investors that the pipeline is not just growing but converting.
A Tale of Two Balance Sheets
Financially, D-Wave presents a split picture. On one hand, the company ended 2025 with record liquidity of roughly $884 million, though the secondary article notes a more recent cash position of around $635 million. Long-term debt stands at a modest $42 million, giving management ample runway to fund operations. On the other hand, the business remains cash-hungry: the last quarter saw negative free cash flow of about $20 million, as heavy investment in technology development continues to consume capital.
Annual revenue for 2025 came in at just under $25 million, underscoring the gap between market capitalization and commercial reality. The company’s order book, however, offers a counter-narrative. Beyond the January surge, D-Wave has been steadily building a backlog that now dwarfs historical levels. The question for investors is whether that backlog can sustain the revenue growth needed to justify the stock’s valuation.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Analyst Divergence and Insider Caution
Wall Street analysts remain broadly bullish, though they have trimmed their price targets. Mizuho cut its target from $40 to $31, while Evercore ISI lowered its to $42. Wedbush held firm at $40, and Canaccord Genuity kept its at $43. All four maintain buy ratings. But independent researchers are more skeptical, with some issuing sell recommendations, citing a disconnect between quantum hype and financial fundamentals. Year-to-date, the stock is down roughly 20%.
Adding to the cautionary signals, insider selling has picked up. Chief People Officer Sophie Ames recently disposed of shares worth roughly $65,000 under a pre-arranged trading plan. Over the past three months, insiders have sold more stock than they have bought. Meanwhile, the share count has expanded by more than a quarter over the past year, diluting existing holders and weighing on sentiment.
The Earnings Reckoning
With the May 12 report looming, the stakes are high. The stock’s post-Nvidia rally has largely evaporated, and the shares are now consolidating in a narrow range near $18.50. Options activity, which had been heavily skewed toward bullish bets during the Nvidia frenzy, has normalized. The next catalyst will be purely fundamental: can D-Wave demonstrate that its order bonanza is translating into revenue growth?
If the company delivers on that front, the selloff may prove to have been a buying opportunity. If not, the stock could face renewed pressure as the gap between hype and reality widens. For now, the market is waiting—and watching the calendar.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from April 25 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.
D-Wave Quantum: Buy or sell? Read more here...









